InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Wednesday, 04/24/2019 1:00:40 PM

Wednesday, April 24, 2019 1:00:40 PM

Post# of 1084
News: $ACHV Achieve Life Sciences Announces Last Subject, Last Visit Completed in Phase 2b ORCA-1 Trial of Cytisinicline for Smoking Cessation

SEATTLE and VANCOUVER, British Columbia , April 24, 2019 /PRNewswire/ -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation, today announced that the la...

Read the whole news https://marketwirenews.com/news-releases/achieve-life-sciences-announces-last-subject-last-visit-completed-in-phase-2b-orca-1-trial-of-cytisinicline-for-smoking-cessation-8047300.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACHV News